Shanghai Pharmaceuticals Holding Co., Ltd. (stock code: 02607) published its monthly return for equity issuer for the period ended 31 October 2025. According to the announcement, the total authorized share capital remained at RMB 3,708,361,809 during the reporting period, comprising 919,072,704 H shares and 2,789,289,105 A shares, both with a par value of RMB 1 each.

The issued share capital also remained unchanged, with 919,072,704 H shares listed in Hong Kong and 2,789,289,105 A shares (stock code: 601607) unlisted in Hong Kong. No additional shares were issued, and no treasury shares were created or cancelled. In the share option segment, 680,000 A-share options at an exercise price of RMB 20.16 remained outstanding, with no options exercised during the month.

Overall, there were no changes to the company’s authorized share capital, issued share capital, or treasury shares during October 2025.